| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Jan 15, 2020 | Option Exercise | $60.00 | 183,384 | 11,003,040 | 0 | Jan 15, 2020, 01:38 PM | |
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Jan 08, 2020 | Option Exercise | $3.28 | 150,888 | 494,897 | 183,384 | Jan 10, 2020, 06:19 PM | |
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Dec 12, 2019 | Option Exercise | $26.64 | 71,460 | 1,903,601 | 53,954 | Dec 16, 2019, 06:05 PM | |
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Dec 05, 2019 | Option Exercise | $59.21 | 505 | 29,901 | 21,314 | Dec 09, 2019, 05:17 PM | |
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Sep 05, 2019 | Option Exercise | $31.02 | 505 | 15,665 | 21,819 | Sep 09, 2019, 04:06 PM | |
| BOLD | Audentes Therapeutics, Inc. | Soloway Thomas P | Executive Vice President, CFO | Jun 05, 2019 | Option Exercise | $37.31 | 1,009 | 37,646 | 22,324 | Jun 07, 2019, 04:40 PM | |
| TSPT | Transcept Pharmaceuticals Inc | Soloway Thomas P | SVP, Operations and CFO | Dec 01, 2011 | Option Exercise | $5.02 | 125,340 | 629,070 | 37,520 | Dec 05, 2011, 07:49 PM | |
| TSPT | Transcept Pharmaceuticals Inc | Soloway Thomas P | SVP, Operations and CFO | Nov 23, 2011 | Sale | $5.27 | 27,200 | 143,412 | 13,600 | Nov 28, 2011, 04:27 PM |
Menu